iDayo Selects PTIE as Low Risk Investment

Call Now
800-993-0005

(^DJI) 0

0S&P 500 (^GSPC) 1320.68

1.82NASDAQ Composite (^IXIC) 2839.38

-10.74Russell 2000 (^RUT) 766.57

1.4

iDayo™ Stock Selector: PTIE - Pain Therapeutics Inc

iDayo™ 08/23/04: Pain Therapeutics Inc (PTIE) - 08/23/04

For the 16 week investment period starting 08/23/04 , the iDayo™ Stock Selector rated Pain Therapeutics Inc (PTIE) as "Extreme Accumulation" and selected PTIE as a buy for the investment period, identified as iDayo™ 08/23/04.

Company Profile for "Pain Therapeutics Inc (PTIE)": Pain Therapeutics, Inc. is a biopharmaceutical company engaged in the development of drugs that target severe chronic pain, such as pain associated with advanced osteoarthritis, low-back pain or irritable bowel syndrome.

Google Finance History for PTIE

iDayo, Inc. (including its marketing professionals and staff), is not a registered Investment Advisor or Broker/Dealer, and does not provide investment advice or recommendations. Subscribers to iDayo™ are advised that the information, opinions, and analysis included in our web sites, on our free Educational Conference Calls, or in any other communication are based in good faith on sources believed to be reliable, but no representation or warranty, expressed or implied, is made as to their accuracy, completeness, or correctness.

Past performance is not necessarily indicative of the future performance of stocks posted. None of these postings, the iDayo™ system rating, nor any other information provided on our web sites, on our free Educational Conference Calls, or in any other communication constitutes a recommendation to buy or sell stocks or any other investment. Investing involves the risk of loss and Subscribers are urged to consult with their own independent financial advisors with respect to any investment.